Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D P Merke

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
The New England Journal of Medicine|April 17, 1999
Adrenal lymphocytic infiltration and adrenocortical tumors in a patient with 21-hydroxylase deficiencyD P Merke, S R Bornstein, D Braddock, et al.
The Journal of Clinical Endocrinology and Metabolism|September 24, 1998
Therapeutic controversy: The role of laparoscopic surgery in adrenal diseaseS A Wells, D P Merke, G B Cutler, et al.
The Journal of Clinical Endocrinology and Metabolism|March 7, 2001
Hydrocortisone suspension and hydrocortisone tablets are not bioequivalent in the treatment of children with congenital adrenal hyperplasiaD P Merke, D Cho, K A Calis, et al.
American Journal of Epidemiology|March 1, 1988
The risk factors for arrhythmic death in a sample of men followed for 20 yearsL E Hinkle, H T Thaler, D P Merke, et al.
AJR. American Journal of Roentgenology|May 5, 1999
Testicular adrenal rest tissue in congenital adrenal hyperplasia: serial sonographic and clinical findingsN A Avila, T S Shawker, J V Jones, et al.
The Journal of Clinical Endocrinology and Metabolism|March 17, 2000
Flutamide, testolactone, and reduced hydrocortisone dose maintain normal growth velocity and bone maturation despite elevated androgen levels in children with congenital adrenal hyperplasiaD P Merke, M F Keil, J V Jones, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1996
A preliminary study of flutamide, testolactone, and reduced hydrocortisone dose in the treatment of congenital adrenal hyperplasiaL Laue, D P Merke, J V Jones, et al.
The Journal of Clinical Endocrinology and Metabolism|January 22, 1998
Novel CYP11B1 mutations in congenital adrenal hyperplasia due to steroid 11 beta-hydroxylase deficiencyD P Merke, T Tajima, A Chhabra, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|May 7, 2010
Adrenomedullary function in patients with nonclassic congenital adrenal hyperplasiaS Verma, L Green-Golan, C VanRyzin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1990
Prognostic factors among 185 adults with newly diagnosed advanced Hodgkin's disease treated with alternating potentially noncross-resistant chemotherapy and intermediate-dose radiation therapyD J Straus, J J Gaynor, J Myers, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
The New England Journal of Medicine|April 17, 1999
Adrenal lymphocytic infiltration and adrenocortical tumors in a patient with 21-hydroxylase deficiencyD P Merke, S R Bornstein, D Braddock, et al.
The Journal of Clinical Endocrinology and Metabolism|September 24, 1998
Therapeutic controversy: The role of laparoscopic surgery in adrenal diseaseS A Wells, D P Merke, G B Cutler, et al.
The Journal of Clinical Endocrinology and Metabolism|March 7, 2001
Hydrocortisone suspension and hydrocortisone tablets are not bioequivalent in the treatment of children with congenital adrenal hyperplasiaD P Merke, D Cho, K A Calis, et al.
American Journal of Epidemiology|March 1, 1988
The risk factors for arrhythmic death in a sample of men followed for 20 yearsL E Hinkle, H T Thaler, D P Merke, et al.
AJR. American Journal of Roentgenology|May 5, 1999
Testicular adrenal rest tissue in congenital adrenal hyperplasia: serial sonographic and clinical findingsN A Avila, T S Shawker, J V Jones, et al.
The Journal of Clinical Endocrinology and Metabolism|March 17, 2000
Flutamide, testolactone, and reduced hydrocortisone dose maintain normal growth velocity and bone maturation despite elevated androgen levels in children with congenital adrenal hyperplasiaD P Merke, M F Keil, J V Jones, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1996
A preliminary study of flutamide, testolactone, and reduced hydrocortisone dose in the treatment of congenital adrenal hyperplasiaL Laue, D P Merke, J V Jones, et al.
The Journal of Clinical Endocrinology and Metabolism|January 22, 1998
Novel CYP11B1 mutations in congenital adrenal hyperplasia due to steroid 11 beta-hydroxylase deficiencyD P Merke, T Tajima, A Chhabra, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|May 7, 2010
Adrenomedullary function in patients with nonclassic congenital adrenal hyperplasiaS Verma, L Green-Golan, C VanRyzin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1990
Prognostic factors among 185 adults with newly diagnosed advanced Hodgkin's disease treated with alternating potentially noncross-resistant chemotherapy and intermediate-dose radiation therapyD J Straus, J J Gaynor, J Myers, et al.
Pageof 3